
  
    
      
        
        There_EX is_VBZ a_DT well-documented_JJ relationship_NN between_IN short_JJ sleep_NN duration_NN and_CC high_JJ body_NN mass_NN
        index_NN (_( BMI_NNP )_) ._. In_IN the_DT largest_JJS study_NN ,_, a_DT survey_NN on_IN sleep_NN duration_NN and_CC frequency_NN of_IN insomnia_NN in_IN
        more_JJR than_IN 1_CD ._. 1_CD million_CD participants_NNS ,_, increasing_VBG BMI_NNP occurred_VBD for_IN habitual_NN sleep_NN amounts_NNS
        below_IN 7_CD –_NN 8_CD hours_NNS [_NN 1_CD ]_NN ._. A_DT recent_JJ prospective_JJ study_NN found_VBD an_DT association_NN between_IN sleep_NN
        curtailment_NN and_CC future_JJ weight_NN gain_NN [_NN 2_CD ]_NN ._. The_DT mechanism_NN linking_VBG short_JJ sleep_NN with_IN weight_NN gain_NN
        is_VBZ unknown_JJ ,_, but_CC Mignot_NNP and_CC colleagues_NNS '_POS study_NN in_IN this_DT month_NN 's_POS 
        PLoS_NNP Medicine_NNP [_NN 3_CD ]_NN adds_VBZ to_TO the_DT growing_VBG evidence_NN implicating_VBG leptin_NN and_CC
        ghrelin_NN ,_, the_DT two_CD key_JJ opposing_VBG hormones_NNS involved_VBN in_IN appetite_NN regulation_NN ._.
      
      
        Hormones_NNP That_DT Regulate_NNP Appetite_NNP
        Leptin_NNP ,_, a_DT peptide_NN hormone_NN secreted_JJ from_IN white_JJ adipocytes_NNS ,_, is_VBZ implicated_VBN in_IN the_DT
        regulation_NN of_IN food_NN intake_NN and_CC energy_NN balance_NN ._. The_DT hormone_NN acts_NNS on_IN the_DT central_JJ nervous_JJ
        system_NN ,_, in_IN particular_JJ the_DT hypothalamus_JJ ,_, suppressing_VBG food_NN intake_NN and_CC stimulating_VBG energy_NN
        expenditure_NN ._. Leptin_NNP production_NN is_VBZ primarily_RB regulated_VBN by_IN insulin-induced_JJ changes_NNS in_IN
        adipocyte_NN metabolism—its_NNS secretion_NN levels_NNS correlate_VBP with_IN adipocyte_NN mass_NN and_CC lipid_NN
        loads_NNS ._.
        Leptin_NNP promotes_VBZ inflammation_NN ._. The_DT hormone_NN provides_VBZ an_DT interesting_JJ link_NN between_IN obesity_NN
        and_CC pathophysiological_JJ processes_VBZ such_JJ as_IN insulin_NN resistance_NN and_CC atherosclerosis_NNS ,_, and_CC
        disorders_NNS such_JJ as_IN autoimmune_JJ and_CC cardiovascular_JJ diseases_NNS and_CC the_DT metabolic_JJ syndrome_NN ._.
        Increased_VBN serum_NN leptin_NN levels_NNS in_IN obesity_NN and_CC metabolic_JJ syndrome_NN support_NN the_DT view_NN that_IN these_DT
        disorders_NNS are_VBP in_IN fact_NN low-grade_JJ systemic_JJ inflammatory_JJ diseases_NNS ,_, characterized_VBN by_IN increased_VBN
        concentrations_NNS of_IN proinflammatory_NN cytokines_NNS like_IN interleukin-_NN 6_CD ,_, tumor_NN necrosis_NNS factor-α_JJ and_CC
        leptin_NN ._. Leptin_NNP 's_POS proinflammatory_NN role_NN suggests_VBZ that_IN it_PRP may_MD link_VB energy_NN homeostasis_NNS to_TO the_DT
        immune_JJ system_NN [_NN 4_CD ,_, 5_CD ]_NN ._. Ghrelin_NNP is_VBZ a_DT peptide_NN hormone_NN that_IN stimulates_NNS appetite_NN ,_, fat_JJ production_NN ,_,
        and_CC body_NN growth—leading_VBG to_TO increased_VB food_NN intake_NN and_CC body_NN weight_NN ._. It_PRP is_VBZ secreted_JJ into_IN the_DT
        circulation_NN from_IN the_DT stomach_NN ,_, but_CC is_VBZ also_RB synthesised_JJ in_IN a_DT number_NN of_IN other_JJ tissues_NNS ,_,
        including_VBG the_DT kidney_NN ,_, pituitary_JJ ,_, and_CC hypothalamus_JJ ,_, suggesting_VBG that_IN the_DT hormone_NN has_VBZ both_DT
        distant_JJ and_CC local_JJ (_( endocrine_NN and_CC paracrine_NN )_) effects_NNS ._. These_DT effects_NNS include_VBP stimulating_VBG the_DT
        secretion_NN of_IN growth_NN hormone_NN ,_, prolactin_NN ,_, and_CC adrenocorticotropic_JJ hormone_NN ,_, and_CC a_DT diabetogenic_JJ
        effect_NN on_IN carbohydrate_NN metabolism_NN [_NN 6_CD ]_NN ._.
      
      
        The_DT New_NNP Study_NNP
        In_IN this_DT study_NN of_IN 1_CD ,_, 024_CD participants_NNS in_IN the_DT population-based_JJ Wisconsin_NNP Sleep_VBP Cohort_NNP Study_NNP
        [_NN 7_CD ]_NN ,_, Mignot_NNP and_CC colleagues_NNS found_VBD that_IN in_IN persons_NNS sleeping_VBG less_JJR than_IN 8_CD hours_NNS ,_, increased_VBD BMI_NNP
        was_VBD proportional_JJ to_TO decreased_VBD sleep_VB [_NN 3_CD ]_NN ._. The_DT researchers_NNS also_RB found_VBD that_IN shorter_JJR sleep_NN
        times_NNS were_VBD associated_VBN with_IN increased_VBN circulating_VBG ghrelin_NN and_CC decreased_VBD leptin_NN ,_, a_DT hormonal_NN
        pattern_NN that_WDT is_VBZ consistent_JJ with_IN decreased_VBD energy_NN expenditure_NN and_CC increased_VBN appetite_NN and_CC
        obesity_NN ._.
        These_DT findings_NNS confirm_VBP earlier_JJR clinical_JJ reports_NNS on_IN the_DT effects_NNS of_IN sleep_NN deprivation_NN and_CC
        extend_VB them_PRP to_TO include_VB naturalistic_JJ sleep_NN in_IN a_DT large_JJ ,_, community-based_JJ population_NN ._. The_DT study_NN
        provides_VBZ an_DT exciting_JJ addition_NN to_TO the_DT growing_VBG literature_NN showing_VBG relationships_NNS between_IN sleep_NN
        curtailment_NN ,_, metabolic_JJ hormones_NNS ,_, and_CC metabolic_JJ disorders_NNS (_( including_VBG obesity_NN )_) ._. The_DT data_NNS have_VBP
        important_JJ implications_NNS for_IN our_PRP$ understanding_NN of_IN obesity_NN and_CC related_VBN disorders_NNS in_IN the_DT
        general_JJ population_NN ,_, with_IN one_CD caveat_NN :_: the_DT study_NN population_NN was_VBD enriched_JJ with_IN snorers_NNS ,_, making_VBG
        the_DT results_NNS less_RBR applicable_JJ to_TO a_DT general_JJ population_NN ._.
        Mignot_NNP and_CC colleagues_NNS '_POS data_NNS are_VBP in_IN accord_NN with_IN human_NN and_CC animal_NN studies_NNS that_WDT show_NN that_IN
        experimental_JJ curtailment_NN of_IN sleep_NN leads_VBZ to_TO lower_JJR levels_NNS of_IN leptin_NN [_NN 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ]_NN and_CC increased_VBN
        ghrelin_NN [_NN 12_CD ]_NN ._. The_DT new_JJ study_NN therefore_RB lends_VBZ some_DT support_NN to_TO the_DT interpretation_NN that_WDT reduced_VBD
        sleep_VB levels_NNS cause_VB the_DT hormonal_NN changes_NNS ._.
        But_CC there_EX is_VBZ also_RB evidence_NN of_IN opposite_JJ effects—that_NN is_VBZ ,_, that_DT administration_NN of_IN leptin_NN
        [_NN 13_CD ]_NN and_CC ghrelin_NN can_MD alter_VB sleep_VB ._. Ghrelin_NNP administration_NN has_VBZ been_VBN found_VBN to_TO increase_VB non-_NN REM_NNP
        sleep_VB in_IN humans_NNS and_CC mice_NNS ,_, possibly_RB via_IN its_PRP$ interactions_NNS with_IN the_DT sleep-inducing_JJ peptide_NN
        growth_NN hormone_NN releasing_VBG hormone_NN (_( GHRH_NNP )_) ._. Ghrelin_NNP is_VBZ an_DT endogenous_JJ ligand_NN of_IN the_DT growth_NN
        hormone_NN secretagogue_NN receptor_NN ,_, making_VBG it_PRP a_DT candidate_NN for_IN an_DT endogenous_JJ sleep-promoting_JJ
        factor_NN [_NN 14_CD ]_NN ._. Mignot_NNP and_CC colleagues_NNS '_POS study_NN is_VBZ congruent_NN with_IN the_DT idea_NN that_IN inadequate_JJ sleep_NN
        enhances_VBZ ghrelin_NN secretion_NN ,_, which_WDT in_IN turn_NN acts_NNS as_IN an_DT endogenous_JJ sleep_NN factor_NN in_IN humans_NNS ._.
        This_DT is_VBZ an_DT important_JJ new_JJ area_NN of_IN research_NN that_WDT could_MD conceivably_RB lead_VB to_TO more_RBR physiological_JJ
        sleep_NN aids_NNS than_IN are_VBP currently_RB available_JJ ,_, with_IN profound_JJ implications_NNS for_IN improved_VBN public_JJ
        health_NN ._.
        Overall_RB ,_, the_DT available_JJ studies_NNS suggest_VBP the_DT presence_NN of_IN reciprocal_JJ interactions_NNS between_IN
        metabolic_JJ hormones_NNS and_CC sleep_VB ,_, relationships_NNS that_WDT are_VBP poorly_RB understood_VBN at_IN present_NN ._. Does_VBZ
        sleep_VB interact_NN with_IN metabolic_JJ hormones_NNS directly_RB or_CC via_IN intervening_VBG factors_NNS such_JJ as_IN
        sleep-related_JJ breathing_NN disorders_NNS ?_. Patients_NNS with_IN obstructive_JJ sleep_NN apnea_NN have_VBP impaired_VBN
        sleep_VB and_CC higher_JJR ghrelin_NN levels_NNS than_IN BMI-matched_NNP controls_NNS ,_, and_CC treatment_NN with_IN continuous_JJ
        positive_JJ airway_NN pressure_NN reduces_VBZ ghrelin_NN to_TO control_VB levels_NNS [_NN 15_CD ]_NN ._. Although_IN sleep-disordered_JJ
        breathing_NN (_( SDB_NNP )_) was_VBD measured_VBN in_IN the_DT present_JJ study_NN ,_, the_DT SDB_NNP analyses_NNS were_VBD not_RB shown_VBN ,_, making_VBG
        it_PRP difficult_JJ to_TO evaluate_VB the_DT influence_NN of_IN SDB_NNP on_IN ghrelin_NN and_CC leptin_NN in_IN this_DT population_NN ._.
        There_EX is_VBZ a_DT clear_JJ need_NN for_IN well-controlled_JJ ,_, population-based_JJ studies_NNS that_WDT allow_VBP us_PRP to_TO
        examine_VB multiple_JJ relevant_JJ factors_NNS simultaneously_RB ._. The_DT present_JJ study_NN highlights_VBZ the_DT
        importance_NN of_IN shortened_VBN sleep_VB in_IN relation_NN to_TO obesity_NN ,_, leptin_NN ,_, and_CC ghrelin_NN ,_, a_DT good_JJ start_NN
        toward_IN this_DT goal_NN ._.
      
      
        Sleep_VBP and_CC Public_NNP Health_NNP
        Many_JJ other_JJ important_JJ questions_NNS remain_VBP ,_, such_JJ as_IN the_DT roles_NNS that_IN other_JJ hormones_NNS ,_, cytokines_NNS ,_,
        and_CC SDB_NNP play_VBP in_IN obesity_NN ._. Many_JJ of_IN the_DT unanswered_JJ questions_NNS have_VBP important_JJ implications_NNS for_IN
        public_JJ health_NN ._. For_IN example_NN ,_, diabetes_NN ,_, visceral_NN obesity_NN ,_, hypertension_NN ,_, and_CC hyperinsulinemia_NN
        commonly_RB aggregate_JJ together_RB in_IN large_JJ populations_NNS ,_, and_CC are_VBP considered_VBN a_DT “ metabolic_JJ syndrome_NN”
        that_WDT has_VBZ been_VBN linked_VBN to_TO SDB_NNP [_NN 16_CD ]_NN and_CC to_TO inflammatory_JJ disorders_NNS [_NN 17_CD ]_NN ._. To_TO what_WP extent_NN does_VBZ
        long-term_JJ sleep_NN curtailment_NN contribute_VB to_TO these_DT and_CC related_VBN public_JJ health_NN issues_NNS ?_.
        The_DT possible_JJ role_NN of_IN sleep_NN restriction_NN in_IN autoimmune_JJ and_CC inflammatory_JJ disorders_NNS is_VBZ of_IN
        particular_JJ interest_NN in_IN light_NN of_IN recent_JJ findings_NNS linking_VBG immune_JJ function_NN with_IN ghrelin_NN and_CC
        leptin_NN ._. Ghrelin_NNP and_CC its_PRP$ receptor_NN are_VBP expressed_VBN in_IN human_JJ T-_NNP lymphocytes_NNS ,_, where_WRB they_PRP can_MD
        inhibit_VB cytokine_NN activation_NN ,_, including_VBG interleukins_NNS ,_, tumor_NN necrosis_NNS factor-α_JJ and_CC leptin_NN
        [_NN 18_CD ]_NN ._. Conversely_RB ,_, leptin_NN stimulates_NNS cytokine_NN activation_NN and_CC immune-cell_JJ proliferation_NN ,_, an_DT
        effect_NN that_IN predisposes_NNS to_TO inflammatory_JJ conditions_NNS [_NN 4_CD ]_NN ._. Is_VBZ it_PRP possible_JJ ,_, then_RB ,_, that_IN
        sleep-related_JJ changes_NNS in_IN leptin_NN and_CC ghrelin_NN influence_NN the_DT development_NN of_IN metabolic_JJ and_CC
        immune_JJ disorders_NNS ?_. Can_MD biologically_RB restorative_JJ sleep_VB reverse_VB disease_NN progression_NN ?_. Can_MD
        biologically_RB restorative_JJ sleep_VB be_VB defined_VBN on_IN the_DT basis_NN of_IN metabolic_JJ hormone_NN responses_NNS ?_.
        Future_JJ research_NN may_MD answer_VB some_DT of_IN these_DT and_CC other_JJ questions_NNS ,_, further_JJ elucidating_VBG the_DT role_NN
        of_IN sleep_NN in_IN public_JJ health_NN ._.
      
    
  
